Cargando…

Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report

BACKGROUND: Mycetoma is a chronic granulomatous subcutaneous infection caused by anaerobic pseudofilamentous bacteria or fungi. It is commonly prevalent in tropical and subtropical countries. Men are more susceptible to the disease due to greater participation in agricultural works. Mycetoma commonl...

Descripción completa

Detalles Bibliográficos
Autores principales: Izri, Arezki, Aljundi, Mohanad, Billard-Pomares, Typhaine, Fofana, Youssouf, Marteau, Anthony, Ferreira, Theo Ghelfenstein, Brun, Sophie, Caux, Frederic, Akhoundi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656693/
https://www.ncbi.nlm.nih.gov/pubmed/33176717
http://dx.doi.org/10.1186/s12879-020-05552-z
_version_ 1783608402953371648
author Izri, Arezki
Aljundi, Mohanad
Billard-Pomares, Typhaine
Fofana, Youssouf
Marteau, Anthony
Ferreira, Theo Ghelfenstein
Brun, Sophie
Caux, Frederic
Akhoundi, Mohammad
author_facet Izri, Arezki
Aljundi, Mohanad
Billard-Pomares, Typhaine
Fofana, Youssouf
Marteau, Anthony
Ferreira, Theo Ghelfenstein
Brun, Sophie
Caux, Frederic
Akhoundi, Mohammad
author_sort Izri, Arezki
collection PubMed
description BACKGROUND: Mycetoma is a chronic granulomatous subcutaneous infection caused by anaerobic pseudofilamentous bacteria or fungi. It is commonly prevalent in tropical and subtropical countries. Men are more susceptible to the disease due to greater participation in agricultural works. Mycetoma commonly involves lower extremities, wherein untreated cases lead to aggressive therapeutic choices, such as amputation of the affected body organs and consequently lifelong disability. CASE PRESENTATION: In this report, we present the rare case of a 58-year-old man, originally from Algeria with a left foot chronic tumefaction of 5 years. In the initial clinical examination, mycetoma was diagnosed based on tumefaction and the presence of multiple sinuses with the emission of white grains. The latter was observed via direct examination. The histopathological analysis demonstrated an actinomycetoma caused by bacteria, as the etiological agent. Imaging showed a bone involvement with osteolysis at the levels of 2nd to 4th metatarsal diaphysis. The mycological and bacterial cultures were both negative. For an accurate diagnosis, the obtained grains were subjected to molecular analysis, targeting the 16S-rDNA gene. Molecular identification yielded Actinomadura madurae as the causal agent, and 800/160 mg of trimethoprim/sulfamethoxazole was prescribed twice a day for 1 year, as a treatment. CONCLUSION: Considering low information about this disease, especially in non-endemic areas, it is of high importance to enhance the knowledge and awareness of clinicians and healthcare providers, in particular in the countries with immigration issues.
format Online
Article
Text
id pubmed-7656693
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76566932020-11-12 Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report Izri, Arezki Aljundi, Mohanad Billard-Pomares, Typhaine Fofana, Youssouf Marteau, Anthony Ferreira, Theo Ghelfenstein Brun, Sophie Caux, Frederic Akhoundi, Mohammad BMC Infect Dis Case Report BACKGROUND: Mycetoma is a chronic granulomatous subcutaneous infection caused by anaerobic pseudofilamentous bacteria or fungi. It is commonly prevalent in tropical and subtropical countries. Men are more susceptible to the disease due to greater participation in agricultural works. Mycetoma commonly involves lower extremities, wherein untreated cases lead to aggressive therapeutic choices, such as amputation of the affected body organs and consequently lifelong disability. CASE PRESENTATION: In this report, we present the rare case of a 58-year-old man, originally from Algeria with a left foot chronic tumefaction of 5 years. In the initial clinical examination, mycetoma was diagnosed based on tumefaction and the presence of multiple sinuses with the emission of white grains. The latter was observed via direct examination. The histopathological analysis demonstrated an actinomycetoma caused by bacteria, as the etiological agent. Imaging showed a bone involvement with osteolysis at the levels of 2nd to 4th metatarsal diaphysis. The mycological and bacterial cultures were both negative. For an accurate diagnosis, the obtained grains were subjected to molecular analysis, targeting the 16S-rDNA gene. Molecular identification yielded Actinomadura madurae as the causal agent, and 800/160 mg of trimethoprim/sulfamethoxazole was prescribed twice a day for 1 year, as a treatment. CONCLUSION: Considering low information about this disease, especially in non-endemic areas, it is of high importance to enhance the knowledge and awareness of clinicians and healthcare providers, in particular in the countries with immigration issues. BioMed Central 2020-11-11 /pmc/articles/PMC7656693/ /pubmed/33176717 http://dx.doi.org/10.1186/s12879-020-05552-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Izri, Arezki
Aljundi, Mohanad
Billard-Pomares, Typhaine
Fofana, Youssouf
Marteau, Anthony
Ferreira, Theo Ghelfenstein
Brun, Sophie
Caux, Frederic
Akhoundi, Mohammad
Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report
title Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report
title_full Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report
title_fullStr Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report
title_full_unstemmed Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report
title_short Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report
title_sort molecular identification of actinomadura madurae isolated from a patient originally from algeria; observations from a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656693/
https://www.ncbi.nlm.nih.gov/pubmed/33176717
http://dx.doi.org/10.1186/s12879-020-05552-z
work_keys_str_mv AT izriarezki molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport
AT aljundimohanad molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport
AT billardpomarestyphaine molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport
AT fofanayoussouf molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport
AT marteauanthony molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport
AT ferreiratheoghelfenstein molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport
AT brunsophie molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport
AT cauxfrederic molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport
AT akhoundimohammad molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport